Systemic Sclerosis Associated Interstitial Lung Disease research hub

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

This study looks at a new treatment called belimumab for adults with a lung condition linked to scleroderma. Researchers want to see if it improves lung function and other symptoms, like skin thickening, compared to a dummy treatment.